BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 975067)

  • 1. Fundamental carcinogenic processes and their implications for low dose risk assessment.
    Crump KS; Hoel DG; Langley CH; Peto R
    Cancer Res; 1976 Sep; 36(9 pt.1):2973-9. PubMed ID: 975067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cancer slope factors using different statistical approaches.
    Subramaniam RP; White P; Cogliano VJ
    Risk Anal; 2006 Jun; 26(3):825-30. PubMed ID: 16834636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mathematical dose-effect models in the study of carcinogenesis].
    Parfenov IuD
    Vopr Onkol; 1986; 32(1):9-22. PubMed ID: 3511610
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose response problems in carcinogenesis.
    Crump KS
    Biometrics; 1979 Mar; 35(1):157-67. PubMed ID: 497333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologically based models for risk assessment.
    Portier CJ; Hoel DG; Kaplan NL; Kopp A
    IARC Sci Publ; 1990; (104):20-8. PubMed ID: 2228117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicological basis for evaluating health risk].
    Rolecki R; Dutkiewicz T; Kończalik J
    Med Pr; 1992; 43(3):173-81. PubMed ID: 1406237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear interpolation algorithm for low dose risk assessment of toxic substances.
    Gaylor DW; Kodell RL
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):305-12. PubMed ID: 7217854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of risk assessment from data of experimental carcinogenesis studies].
    Roller M; Csicsaky M; Pott F
    Zentralbl Hyg Umweltmed; 1992 Mar; 192(6):479-93. PubMed ID: 1315551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved procedure for low-dose carcinogenic risk assessment from animal data.
    Crump KS
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):339-48. PubMed ID: 6520736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
    Gaylor DW; Swirsky Gold L
    Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assessment of low-dose carcinogenicity.
    Armitage P
    Biometrics; 1982 Mar; 38 Suppl():119-39. PubMed ID: 7046818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
    Snow ET; Sykora P; Durham TR; Klein CB
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
    Calabrese EJ
    Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
    Sanner T; Dybing E; Willems MI; Kroese ED
    Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative evaluation for risk assessment of neoplasms caused by exposure to chemical substances].
    Szymczak W
    Med Pr; 2000; 51(6):625-36. PubMed ID: 11288691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of some aspects of quantitative risk assessment.
    Fishbein L
    J Toxicol Environ Health; 1980; 6(5-6):1275-96. PubMed ID: 7007657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.